Globus Medical
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Globus Medical and other ETFs, options, and stocks.About GMED
Globus Medical, Inc. operates as a medical device company that develops and commercializes healthcare solutions. The firm engages in developing products that promote healing in patients with musculoskeletal disorders.
GMED Key Statistics
Stock Snapshot
The current Globus Medical(GMED) stock price is $84.71, with a market capitalization of 11.44B. The stock trades at a price-to-earnings (P/E) ratio of 27.45.
On 2025-11-12, Globus Medical(GMED) stock traded between a low of $84.55 and a high of $86.26. Shares are currently priced at $84.71, which is +0.2% above the low and -1.8% below the high.
Globus Medical(GMED) shares are trading with a volume of 1.73M, against a daily average of 2.94M.
During the past year, Globus Medical(GMED) stock moved between $51.79 at its lowest and $94.93 at its peak.
During the past year, Globus Medical(GMED) stock moved between $51.79 at its lowest and $94.93 at its peak.
GMED News
Globus Medical (GMED) shares got a boost after management raised full-year financial guidance following strong Q3 results. Revenue and earnings outpaced analyst...
Globus Medical ((GMED)) has held its Q3 earnings call. Read on for the main highlights of the call. Meet Your ETF AI Analyst Discover how TipRanks' ETF AI Analy...
Globus Medical (GMED) is up 33.2%, or $20.50 to $82.21. Meet Your ETF AI Analyst Discover how TipRanks' ETF AI Analyst can help you make smarter investment de...
Analyst ratings
73%
of 15 ratingsMore GMED News
Today’s Market Moving Stocks: Affirm Holdings, Expedia, and Globus Medical By Ian Cooper Nov 7, 2025 10:04 am This post may contain links from our sponsors and...
Shares of Globus Medical (GMED) spiked ~33% on Friday after the orthopedic product maker exceeded Street forecasts with its Q3 2025 financials, prompting Truist...
BTIG analyst Ryan Zimmerman has maintained their neutral stance on GMED stock, giving a Hold rating today. Meet Your ETF AI Analyst Discover how TipRanks' ETF A...
Globus Medical, the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Caitlin Cronin from Canaccord Genuity maintained a Buy...
Needham analyst David Saxon has maintained their neutral stance on GMED stock, giving a Hold rating on October 28. Meet Your ETF AI Analyst Discover how TipRank...
Globus Medical reported third quarter 2025 earnings with sales rising to US$769.05 million and net income climbing to US$118.97 million, alongside a boost in it...
Earnings Call Insights Globus Medical raises 2025 EPS guidance to $3.75–$3.85 as Nevro integration accelerates profitability Nov. 06, 2025 9:56 PM ET Globus Med...
